Sotera Health (SHC) IPO Opens 17% Higher

Today's IPO for Sotera Health Company (NASDAQ: SHC) opened for trading at $27 after pricing its initial public offering (“IPO”) of 46,600,000 shares of its common stock at a price to the public of $23 per share.

The Company has granted the underwriters a 30-day option to purchase up to an additional 6,990,000 shares.

J.P. Morgan, Credit Suisse, Goldman Sachs & Co. LLC and Jefferies are acting as joint lead book-running managers and as representatives of the underwriters for the offering. Barclays, Citigroup and RBC Capital Markets are acting as joint book-running managers for the offering. BNP PARIBAS, KeyBanc Capital Markets, Citizens Capital Markets, ING, Academy Securities, Loop Capital Markets, Penserra Securities LLC, Siebert Williams Shank and Tigress Financial Partners are acting as co-managers for the offering.

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

You May Also Be Interested In

• Lyntris launches IPO at $19-$22 per share on NYSE
• Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
• Goldman Sachs notes European banks trail US peers in equities